Impact of MicroRNAs on Cardiovascular Diseases and Aging

Overview

Journal J Int Med Res

Publisher Sage Publications

Specialty General Medicine

Date 2024 Oct 7

PMID 39370977

Authors

Md Sayed Ali Sheikh

Umme Salma

Affiliations

Soon will be listed here.

Abstract

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality for both men and women among all ethnicities worldwide. Although significant improvements in the management of CVD occurred in the 20th century, non-invasive, universal, early diagnostic biomarkers and newer therapeutic drugs are needed for clinical treatment by physicians. MicroRNAs (miRNAs) are a class of endogenous, non-coding, single-stranded, small RNA molecules that are critically controlled by all human biological processes. Moreover, dysregulated miRNA expression is directly involved in various CVDs, including stable coronary artery disease and acute coronary syndrome. Several miRNAs that are enriched in the plasma of CVD patients have potential as clinical biomarkers, and overexpression or inhibition of specific miRNAs has novel therapeutic significance in the management of CVD. Aging is a multifactorial physiological process that gradually deteriorates tissue and organ function and is considered a non-modifiable major risk factor for CVDs. Recently, several studies established that various miRNAs essentially regulate aging and aging-related disease processes. This narrative review briefly discusses the recently updated molecular involvement of miRNAs in CVDs, their possible diagnostic, prognostic, and therapeutic value, and their relationship to the aging process.

References

Zhu X, Hu J, Xie L . The interplay of long noncoding RNA HULC with microRNA-128-3p and their correlations with lipid level, stenosis degree, inflammatory cytokines, and cell adhesion molecules in coronary heart disease patients. Ir J Med Sci. 2022; 191(6):2597-2603. DOI: 10.1007/s11845-021-02900-z. View

Xu L, Fu T, Wang Y, Ji N . Diagnostic value of peripheral blood miR-296 combined with vascular endothelial growth factor B on the degree of coronary artery stenosis in patients with coronary heart disease. J Clin Ultrasound. 2023; 51(3):520-529. DOI: 10.1002/jcu.23433. View

Lee Y, Wu Y, Lee H, Wang H, Hung C, Chang C . Hsa-miR-409-3p regulates endothelial progenitor senescence via PP2A-P38 and is a potential ageing marker in humans. J Cell Mol Med. 2023; 27(5):687-700. PMC: 9983318. DOI: 10.1111/jcmm.17691. View

Baethge C, Goldbeck-Wood S, Mertens S . SANRA-a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019; 4:5. PMC: 6434870. DOI: 10.1186/s41073-019-0064-8. View

Gonzalez-Lopez P, Alvarez-Villarreal M, Ruiz-Simon R, Lopez-Pastor A, Vega de Ceniga M, Esparza L . Role of miR-15a-5p and miR-199a-3p in the inflammatory pathway regulated by NF-κB in experimental and human atherosclerosis. Clin Transl Med. 2023; 13(8):e1363. PMC: 10442475. DOI: 10.1002/ctm2.1363. View

Vancheri C, Morini E, Prandi F, Barilla F, Romeo F, Novelli G . Downregulation of Circulating Hsa-miR-200c-3p Correlates with Dyslipidemia in Patients with Stable Coronary Artery Disease. Int J Mol Sci. 2023; 24(2). PMC: 9865013. DOI: 10.3390/ijms24021112. View

Meng L, Yu X, Han H, Jia X, Hu B, Zhang L . Circulating miR-143 and miR-145 as promising biomarkers for evaluating severity of coronary artery stenosis in patients with acute coronary syndrome. Clin Biochem. 2022; 111:32-40. DOI: 10.1016/j.clinbiochem.2022.10.004. View

Bestepe F, Fritsche C, Lakhotiya K, Niosi C, Ghanem G, Martin G . Deficiency of miR-409-3p improves myocardial neovascularization and function through modulation of DNAJB9/p38 MAPK signaling. Mol Ther Nucleic Acids. 2023; 32:995-1009. PMC: 10276151. DOI: 10.1016/j.omtn.2023.05.021. View

Abdelmaksoud N, Sallam A, Abulsoud A, El-Dakroury W, Mageed S, Al-Noshokaty T . Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Alzheimer's disease. Pathol Res Pract. 2023; 253:155007. DOI: 10.1016/j.prp.2023.155007. View

10.

Wang Y, Jin B, Chen Q, Yan B, Liu Z . MicroRNA-29b upregulation improves myocardial fibrosis and cardiac function in myocardial infarction rats through targeting SH2B3. Eur Rev Med Pharmacol Sci. 2019; 23(22):10115-10122. DOI: 10.26355/eurrev_201911_19581. View

11.

Bays H, Kulkarni A, German C, Satish P, Iluyomade A, Dudum R . Ten things to know about ten cardiovascular disease risk factors - 2022. Am J Prev Cardiol. 2022; 10:100342. PMC: 9061634. DOI: 10.1016/j.ajpc.2022.100342. View

12.

Bukauskas T, Mickus R, cereskevicius D, Macas A . Value of Serum miR-23a, miR-30d, and miR-146a Biomarkers in ST-Elevation Myocardial Infarction. Med Sci Monit. 2019; 25:3925-3932. PMC: 6556071. DOI: 10.12659/MSM.913743. View

13.

Jayawardena E, Medzikovic L, Ruffenach G, Eghbali M . Role of miRNA-1 and miRNA-21 in Acute Myocardial Ischemia-Reperfusion Injury and Their Potential as Therapeutic Strategy. Int J Mol Sci. 2022; 23(3). PMC: 8836257. DOI: 10.3390/ijms23031512. View

14.

Liu P, Wang S, Li K, Yang Y, Man Y, Du F . Exosomal microRNA‑4516, microRNA‑203 and SFRP1 are potential biomarkers of acute myocardial infarction. Mol Med Rep. 2023; 27(6). PMC: 10206682. DOI: 10.3892/mmr.2023.13010. View

15.

Carini G, Mingardi J, Bolzetta F, Cester A, Bolner A, Nordera G . miRNome Profiling Detects miR-101-3p and miR-142-5p as Putative Blood Biomarkers of Frailty Syndrome. Genes (Basel). 2022; 13(2). PMC: 8872439. DOI: 10.3390/genes13020231. View

16.

Huang J, Chang C, Kuo C, Huang K, Sokal E, Chen K . Exosomal microRNAs miR-30d-5p and miR-126a-5p Are Associated with Heart Failure with Preserved Ejection Fraction in STZ-Induced Type 1 Diabetic Rats. Int J Mol Sci. 2022; 23(14). PMC: 9318774. DOI: 10.3390/ijms23147514. View

17.

Coban N, Erkan A, Ozuynuk-Ertugrul A, Ekici B . Investigation of miR-26a-5p and miR-19a-3p expression levels in angiographically confirmed coronary artery disease. Acta Cardiol. 2023; 78(8):945-956. DOI: 10.1080/00015385.2023.2227484. View

18.

Dong M, Chen D, Zhu Y, Yang S, Kumar S, Zhang R . Impaired regulation of MMP2/16-MLCK3 by miR-146a-5p increased susceptibility to myocardial ischaemic injury in aging mice. Cardiovasc Res. 2022; 119(3):786-801. PMC: 10153423. DOI: 10.1093/cvr/cvac104. View

19.

Cheng M, Yang Z, Qiao L, Yang Y, Deng Y, Zhang C . AGEs induce endothelial cells senescence and endothelial barrier dysfunction via miR-1-3p/MLCK signaling pathways. Gene. 2022; 851:147030. DOI: 10.1016/j.gene.2022.147030. View

20.

Gatsiou A, Georgiopoulos G, Vlachogiannis N, Pfisterer L, Fischer A, Sachse M . Additive contribution of microRNA-34a/b/c to human arterial ageing and atherosclerosis. Atherosclerosis. 2021; 327:49-58. DOI: 10.1016/j.atherosclerosis.2021.05.005. View